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Summary  Toxoplasma  gondii  (T.  gondii) is  a  protozoan  parasite  that  can  cause
toxoplasmosis  in  humans.  However,  there  is  no  current  data  regarding  Toxoplasma
infection  among  individuals  who  were  referred  to  medical  laboratories  in  Mazan-
daran  province  (northern  Iran).  Therefore,  we  performed  a  population-based  study
of  Toxoplasma  seroprevalence  in  this  region.  A  total  of  1832  sera  samples  (from
654  men  and  1178  women)  were  collected  from  people  who  were  referred  to  medi-
cal  laboratories  in  different  cities  throughout  Mazandaran  province  between  March
and  July  2012.  The  serum  titers  of  anti-T. gondii  IgG  and  IgM  were  measured  using
enzyme-linked  immunosorbent  assays.  The  seroprevalence  of  anti-Toxoplasma  IgG
was  55.5%;  and  14.4%  of  the  positive  samples  were  seropositive  for  anti-Toxoplasma
IgM.  The  highest  seroprevalence  was  observed  among  people  who  were  >50  years
old  (90.6%),  and  the  lowest  seroprevalence  was  observed  among  children  who  were
0—9  years  old  (9.4%;  P  <  0.001).  There  was  no  signiﬁcant  difference  in  the  sero-
prevalences  for  each  sex  in  the  study  population.  However,  a  regional  sex-speciﬁc
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difference  in  seroprevalence  was  observed  between  men  (54.1%)  and  women  (70.6%;
P  =  0.003)  in  the  western  cities  of  Mazandaran.  As  the  seroprevalence  of  T.  gondii  in
western  and  eastern  Mazandaran  was  higher  than  that  in  the  central  cities,  there  is  a
need  to  evaluate  the  nature  of  the  infection  chain  in  these  areas.
©  2015  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
ed.
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ative humidity  is  typically  70—100%.  This  study  was
approved  by  the  Research  Ethical  Committee  of
Mazandaran  University  of  Medical  Sciences,  Iran.  AllLimited.  All  rights  reserv
Introduction
Toxoplasma  gondii  (T.  gondii)  is  an  obligate
intracellular  protozoan  parasite  that  can  cause
toxoplasmosis  in  a  wide  range  of  warm-blooded
animals,  including  humans.  The  human  immune
system typically  ensures  that  T.  gondii  infection
is asymptomatic,  subclinical,  or  mild  in  healthy
humans, although  this  parasite  is  an  extremely
successful pathogen.  Therefore,  T.  gondii  can
cause life-threatening  disease  in  individuals  with
encephalitis,  chorioretinitis,  and  lymphadenitis
due to  acquired  infection,  abortion,  neonatal
mortality, and  fetal  abnormalities  (e.g.,  hydro-
cephalus).  Infection  is  also  severe  in  patients
with microcephaly,  intracranial  calciﬁcation,  men-
tal retardation,  seizures  and  blindness  due  to
congenital  infections,  and  severe  encephalitis  due
to acute  infection  or  reactivation  of  a latent
infection in  immunosuppressed  individuals  (e.g.,
patients  with  AIDS,  immunosuppressive  cancer,  and
transplant  recipients)  [1—7].
Humans acquire  toxoplasmosis  through  various
routes,  including  the  ingestion  or  handling  of  under-
cooked  or  raw  meats  that  contain  cysts  with  viable
bradyzoites  and/or  unwashed  vegetables  or  water
that is  contaminated  with  oocysts  that  were  shed  by
cats and  other  felids.  Other  routes  of  acquisition
include blood  transfusion,  organ  transplantation,
and congenital  acquisition  via  the  transplacental
transfer of  tachyzoites,  especially  when  the  mother
becomes  infected  for  the  ﬁrst  time  while  she  is
pregnant  [8—11].  Nevertheless,  toxoplasmosis  is
not a  reportable  disease  and  its  reported  preva-
lence is  only  based  on  regional  studies.  Thus,  the
prevalence  of  T.  gondii  infection  varies  widely,  and
is dependent  on  socioeconomic  conditions,  eat-
ing habits,  geographic  and  climatic  factors,  and
lifestyle  [12—14]. Approximately  one-third  of  the
global  population  is  estimated  to  be  infected  with
T. gondii  [8,15],  although  a  1978  study  from  north-
ern Iran  reported  that  approximately  55.7%  of  the
p
s
eopulation  was  seropositive  for  T.  gondii  [16].  Var-
ous seroprevalences  have  been  reported  among
omen who  were  referred  to  medical  laboratories
efore marriage  (74.6%)  [17], women  with  a  history
f abortion  (37.5%)  [18],  pregnant  women  (71%)
19], students  (22%)  [20], children  with  intellec-
ual  disabilities  (77.4%)  [21],  individuals  with  HIV  or
IDS (77.4%)  [22], and  patients  with  schizophrenia
72.5%) [23].  Furthermore,  other  authors  have  eval-
ated the  seroprevalences  among  butchers  (87.8%)
24], cats  (40%)  [25],  and  farm  animals  (30%  in  goats
nd 35%  in  sheep)  [26].
This study  was  designed  to  provide  recent  data
egarding Toxoplasma  infection  among  individu-
ls who  were  referred  to  medical  laboratories  in
azandaran  province,  northern  Iran.  This  study
sed a population-based  design  to  evaluate  the
oxoplasma  seroprevalence  (IgG  and  IgM)  in  this
egion, which  is  located  near  the  Caspian  Sea.
uestionnaires were  also  used  to  investigate  the
pidemiological  factors  that  were  associated  with
oxoplasma  seropositivity.
aterials and methods
n  this  population-based  cross-sectional  study,  we
ollected 1832  sera  samples  (from  654  men  and
178 women;  0—65  years  old)  from  all  individuals
ho were  referred  to  medical  laboratories  in  cities
hroughout  Mazandaran  province  between  March
nd July  2012.  Mazandaran  province  is located  on
he south  coast  of  the  Caspian  Sea,  and  the  sum-
er temperature  is  typically  20—35 ◦C;  the  winter
emperature rarely  drops  below  0 ◦C. The  annual
ainfall is  approximately  800—1200  mm  and  the  rel-articipants were  provided  written  informed  con-
ent after  the  study’s  purpose  and  procedures  were
xplained.
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moxoplasmosis  seroprevalence  during  laboratory  tes
Each  participant  completed  a  questionnaire
egarding  their  demographic  information,  and  a 5-
L blood  sample  was  obtained  via  venipuncture
nder sterile  conditions.  The  blood  samples  were
ept in  a  standard  ice-packed  storage  box  and
ere transported  to  the  Department  of  Parasitol-
gy at  Mazandaran  University  of  Medical  Sciences
or analysis.  Serum  samples  were  obtained  via  cen-
rifugation  at  1000  RPM  for  10  min  and  were  stored
t −80 ◦C  until  use.  The  titers  of  anti-T.  gondii
gG and  IgM  were  measured  using  enzyme-linked
mmunosorbent  assays,  according  to  the  manufac-
urer’s  instructions  (EUROIMMUN,  D-23560  Lubeck,
eekamp  31,  Germany),  and  were  quantiﬁed  using
he optical  density  at  490  nm  in  an  automatic  plate
eader  (SPECTRA,  Molecular  Devices,  USA).  Sera
amples  with  titers  of  ≥20  IU/mL  and  ≥100  IU/mL
ere considered  positive  for  anti-T.  gondii  IgG  and
gM, respectively.
All data  from  the  questionnaire  and  laboratory
ests were  entered,  edited,  and  analyzed  using
PSS software  (version  19.0;  SPSS  Inc.,  Chicago,
L). Before  each  statistical  analysis,  the  initial  data
ntry was  crosschecked  to  conﬁrm  that  the  data
ere  entered  correctly  and  consistently.  The  rela-
ive proportions  were  calculated  using  a  conﬁdence
nterval of  95%.  The  chi-square  test  or  Fisher’s  exact
est were  used  to  analyze  differences  in  the  sero-
revalences  of  anti-T.  gondii  IgG  and  IgM  according
o sex,  age,  and  region.
esults
he  overall  seroprevalence  anti-Toxoplasma  IgG  in
azandaran  province  was  55.5%  (1018/1832),  and
4.4% (147/1018)  of  the  positive  samples  were
lso seropositive  for  anti-Toxoplasma  IgM.  There
as no  sex-speciﬁc  difference  in  the  seropreva-
ences for  men  and  women  in  the  entire  study
opulation (men:  54.4%,  356/654;  women:  56.2%,
s
i
h
s
Table  1  Seroprevalence  of  anti-Toxoplasma  IgG  according
Variables  Number  of  patients  
Sex
Male  654  
Female  1178  
Age  groups  (years)
0—9 254 
10—19 366  
20—29 542  
30—39  250  
40—49  142  
>50  278   77
62/1178;  2 = 0.52,  P >  0.05).  The  highest  sero-
revalence  was  observed  among  participants  who
ere >50  years  old  (90.6%,  252/278),  compared
o 81.7%  (116/142)  among  participants  who  were
0—49 years  old  and  9.4%  (24/254)  among  partic-
pants who  were  0—9  years  old;  these  differences
ere statistically  signiﬁcant  (2 =  15.54,  P  < 0.001)
Table  1).  The  seroprevalence  of  anti-Toxoplasma
gG was  highest  among  residents  of  eastern  cities
Neka and  Behshahr,  65.8%,  277/421)  and  west-
rn cities  (Nowshahr  and  Chalous,  64.7%,  304/471);
entral  cities  had  a signiﬁcantly  lower  seropreva-
ence (46.5%,  437/940;  2 =  23.97,  P  =  0.003).  In
ddition,  women  in  the  western  cities  had  a sig-
iﬁcantly  higher  seroprevalence  (70.6%,  211/299),
ompared  to  the  men  in  the  western  cities  (54.1%,
3/172; 2 = 8.54,  P  = 0.003)  (Table  2).
iscussion
ur  survey  regarding  the  seroprevalence  of  anti-
oxoplasma  IgG  among  residents  of  Mazandaran
rovince revealed  that  55.5%  of  these  individu-
ls had  latent  toxoplasmosis  or  previous  exposure
o this  infection.  This  ﬁnding  indicates  that  toxo-
lasmosis  is  highly  endemic  in  this  region,  and  is
ompatible  with  the  extensive  contact  between  the
opulation  and  potential  sources  of  T.  gondii.
As titers  of  anti-Toxoplasma  IgG  may  remain  ele-
ated for  an  extended  period,  an  increase  in  IgG
iters may  reﬂect  active  primary  infection,  reacti-
ation  of  chronic  infection,  or  a persistent  immune
esponse  to  a  dormant  infection  [27]. In  addition,
gG titers  are  well  correlated  with  the  severity
f infection  and  duration  since  infection.  Further-
ore,  it appears  that  the  presence  of  domestic  andtray cats,  warm  weather,  and  high  humidity,  are
mportant  factors  that  may  be  responsible  for  the
igh seroprevalence  of  anti-Toxoplasma  IgG  in  the
tudied population.
 to  age  and  sex.
Seropositive  patients  N  (%)  P-value
356  (54.4)  >0.05
662  (56.2)
24  (9.4)  <0.001
150  (40.9)
310  (57.2)
166  (66.4)
116  (81.7)
252  (90.6)
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Table  2  Seroprevalence  of  anti-Toxoplasma  IgG  according  to  region.
Region  Seropositive  patients  P-value
Men  Women  Combined
N  (%)  N  (%)  N  (%)
West  93/172  (54.1)  211/299  (70.6)  304/471  (64.5)  0.003
East  103/156  (66)  174/265  (65.7)  277/421  (65.8)  >0.05
Center  160/326  (49.1)  277/614  (45.1)  437/940  (46.5)  >0.05
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NOur  ﬁndings  are  in  agreement  with  those  of
Salehi-Moghaddam  et  al.  and  Shemirani  et  al.,  who
reported  prevalences  of  68.3%  and  55%  for  Tox-
oplasma infection  in  the  general  population  and
among women  who  were  referred  to  gynecology
clinics in  south  Tehran,  respectively  [28,29]. Sim-
ilarly, Assmar  et  al.  reported  a  prevalence  of  51.8%
in the  general  population  of  Iran  during  1997  [30],
and Ghorbani  et  al.  reported  prevalences  of  55.7%
(in rural  northern  Iran)  and  17.7%  (in  Khuzes-
tan province,  southwest  Iran)  during  1981  [31].
The reported  prevalence  of  Toxoplasma  infection
in south  Iran  is  42.7—44.5%  [32].  However,  the
prevalence of  T.  gondii  infection  varies  from  0%
among  Eskimos  to  94%  in  Costa  Rica  and  Guatemala
[33,34].
In the  present  study,  we  found  that  approxi-
mately 10%  of  0 to  9-year-old  children  were  positive
for anti-T.  gondii  IgG.  As  these  children  were  not
exposed  to  soil,  water,  or  food  at  an  early  age,
they are  unlikely  to  undergo  seroconversion  before
adolescence.  Similar  seroprevalences  have  been
reported  among  children  in  Tehran,  Iran  (17.7%)
[35]  and  in  the  nearby  United  Arab  Emirates  [36].
However, children  in  other  countries  have  higher
prevalences,  such  as  17.4%  in  Islamabad,  Pakistan
[37],  12.8%  in  Dublin,  Ireland  [38], and  12.6%  in
Seoul, Korea  [39]. The  highest  seroprevalence  that
we observed  occurred  among  participants  who  were
>50 years  old,  and  this  ﬁnding  is  consistent  with
ﬁndings from  western  Venezuela  [40]  and  urban
populations  in  Venezuela  (87.9%  among  ≥40-year-
old  individuals)  and  Panama  (approximately  90%  in
>60-year-old  individuals)  [41,42].  We  also  observed
that the  seroprevalence  of  T.  gondii  increased
with age,  and  this  ﬁnding  is  consistent  with  sim-
ilar previous  studies  [8,38,43—47].  This  increase
in seroprevalence  is  likely  a  reﬂection  of  the
increasing exposure  as  individuals  age,  with  minor
infections  producing  low  antibody  titers  that  subse-
quently increase  with  age  and  repeated  exposure.
A previous  study  has  reported  that  there  is
no sex-related  difference  in  the  seroprevalence
of toxoplasmosis  [9], and  our  ﬁndings  conﬁrm
C
Nhat  conclusion.  Because  approximately  half  of
he women  in  the  present  study  were  seroneg-
tive for  anti-T.  gondii  IgG,  those  women  are
usceptible to  acute  Toxoplasma  infection  dur-
ng their  childbearing  years,  and  their  infants  are
usceptible  to  congenital  toxoplasmosis.  Unfortu-
ately,  infected  infants  can  develop  chorioretinitis,
onvulsion, jaundice,  hydrocephalus,  fever,  pneu-
onitis, hepatosplenomegaly,  lymphadenopathy,
icrocephalus,  cataracts,  hypothermia,  and  rash
48]. In  addition,  most  children  with  Toxoplasma
nfection only  develop  clinical  manifestations  at
everal years  after  birth  [36,49]. Therefore,  it  is
mportant  that  women  of  childbearing  age,  and
specially  pregnant  women,  be  educated  regarding
he dangers  of  eating  raw  or  undercooked  meat,  as
ell as  regarding  soil-related  hygiene.
onclusions
he  highest  seroprevalence  of  anti-T.  gondii  IgG  was
bserved among  residents  of  the  western  and  east-
rn regions  of  Mazandaran  province.  Although  it  is
ot clear  why  the  residents  of  the  central  cities
ad a  lower  seroprevalence,  this  ﬁnding  may  be
xplained by  a  reduced  exposure  to  various  routes
f T.  gondii  infection.  Nevertheless,  given  that  the
eroprevalence  of  anti-T.  gondii  IgG  was  elevated
n western  and  eastern  Mazandaran,  future  studies
hould  evaluate  the  nature  of  the  infection  chain  in
hese regions.
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